OptimizeRx Corp

OPRX Nasdaq CIK: 0001448431

Company Information

Industry Services-Business Services, NEC
SIC Code 7389
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address 260 CHARLES STREET, WALTHAM, MA, 02453
Mailing Address 260 CHARLES STREET, WALTHAM, MA, 02453
Phone 248-651-6558
Fiscal Year End 1231
EIN 261265381

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events March 30, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
10-K Annual financial report March 12, 2026 View on SEC
8-K Current report of material events March 5, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report December 23, 2025 View on SEC
4/A Insider transaction amendment December 23, 2025 View on SEC
4 Insider stock transaction report December 23, 2025 View on SEC
4 Insider stock transaction report December 23, 2025 View on SEC
4 Insider stock transaction report December 23, 2025 View on SEC

Annual Reports

10-K March 12, 2026
  • Achieved significant profitability in 2023 with $8.5 million net income and 15% revenue growth to $105.2 million.
  • Maintains a robust financial position with $75.3 million cash, no long-term debt, and a 2.8x current ratio.
View Analysis

Insider Trading

SELL 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 7389)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.